Evidence map›Paper›PMID 42497231›Full record

ArticlePLoS computational biology2026

CellExLink: End-to-end cell-type recognition and normalization in biomedical text.

Alimire Nabijiang, Leili Shahriyari

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alimire NabijiangDepartment of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, Massachusetts, United States of America.
Leili ShahriyariDepartment of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-6234-8449

Funding

Advancing Disease Modeling through Mathematical Frameworks: Leveraging Single-Cell Spatial Data to Uncover Tissue-Specific Pathways and Immune ResponsesR35GM159993 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI Leili Shahriyari · 2025 to 2026
$813k
NIGMS NIH HHS R35 GM159993
6 · The paper itself

Abstract

Cell types are described in biomedical literature using diverse names, abbreviations, and phenotype phrases, which complicates their recognition and normalization. We developed CellExLink, an end-to-end pipeline that identifies cell-type mentions and normalizes them to Cell Ontology (CL) identifiers. The recognizer was fine-tuned and evaluated on five heterogeneous biomedical corpora spanning full-length articles, article excerpts, figure captions, abstracts, and anatomical text passages. These resources include fine-grained phenotype-defined populations, heterogeneous cell populations, and abbreviated mentions. Across the five corpora, CellExLink achieved macro-average exact- and relaxed-span F1 scores of 0.766 and 0.855, respectively. For CL identifier normalization on gold-standard mention spans, F1 scores ranged from 0.690 to 0.874. In strict end-to-end evaluation, which required both an exact mention span and the correct CL identifier, F1 scores ranged from 0.552 on a figure-caption corpus to 0.725 on a corpus of full-text article excerpts. CellExLink outperformed the evaluated off-the-shelf systems in cell mention recognition, CL identifier normalization, and end-to-end extraction. By converting unannotated biomedical text into cell-type spans linked to standardized CL identifiers, CellExLink provides a practical foundation for downstream applications, including literature curation, relation extraction, and knowledge graph construction.

Indexed as

CellsComputational BiologyData MiningBiological OntologiesHumansNatural Language Processing

Identifiers

PMID42497231
PMCPMC13436769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.